SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
ANG Lifesciences India Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
540694 INE236W01016 65.2573243 Not Listed 0 72.93 0 0 10
Quarters :
ParticularsDec 2023(Rs.Cr)Sep 2023(Rs.Cr)Jun 2023(Rs.Cr)
Gross Sales17.1029.5850.61
Other Operating Income0.000.000.00
Other Income -0.090.330.34
Total Income17.0129.9150.95
Total Expenditure 18.8228.2644.94
PBIDT-1.801.656.01
Interest 1.991.961.94
PBDT-3.80-0.314.07
Depreciation2.021.971.94
Tax-0.47-0.350.82
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.750.12-0.28
Reported Profit After Tax-4.59-2.051.60
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-4.59-2.051.60
    
EPS (Unit Curr.)-3.51-1.531.28
EPS (Adj) (Unit Curr.)-3.51-1.531.28
Calculated EPS (Unit Curr.)-3.52-1.571.22
Calculated EPS (Adj) (Unit Curr.)-3.52-1.571.22
Calculated EPS (Ann.) (Unit Curr.)-14.06-6.284.89
Calculated EPS (Adj) (Ann.) (Unit Curr.)-14.06-6.284.89
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity13.0613.0613.06
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)-10.535.5811.88
PBDTM(%)-22.22-1.058.04
PATM(%)-26.84-6.933.16